Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. 2001

T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara 634-8522, Japan.

To examine the property of hepatocellular carcinoma (HCC), rat HCC cells were implanted into normal and cirrhotic rat livers. Implanted HCC grew much more progressively in cirrhotic livers than in normal livers. Kupffer cells were decreased profoundly in cirrhotic livers, resulting in markedly impaired phagocytic activity. Furthermore, production of Kupffer cell-related cytokines, such as interleukin-1 beta and tumor necrosis factor-alpha, was decreased profoundly in cirrhotic livers. Our results indicate that liver cirrhosis is a prominent promoting factor in HCC progression, and that markedly depressed Kupffer cell activity may play a role in augmented HCC progression in cirrhotic livers.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007728 Kupffer Cells Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells. Kupffer Cell,Cell, Kupffer,Cells, Kupffer
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
January 1999, Radiology,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
March 2022, Diagnostics (Basel, Switzerland),
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
January 2005, Transplantation proceedings,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
August 2013, Journal of clinical pathology,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
January 2003, Hepato-gastroenterology,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
January 2007, Hepato-gastroenterology,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
February 2021, Abdominal radiology (New York),
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
January 1998, Clinical imaging,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
February 1997, American journal of clinical pathology,
T Tsujimoto, and S Kuriyama, and M Yamazaki, and Y Nakatani, and H Okuda, and H Yoshiji, and H Fukui
September 2001, Radiology,
Copied contents to your clipboard!